Top

Published in:

01-09-2005 | Clinical trial

Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel Followed by Epirubicin in Stage II/III Breast Cancer

Authors: Bhuvaneswari Ramaswamy, Steven P Povoski, Chris Rhoades, Joan Allen, Marsha Hauger, Donn Young, William Burak, William Farrar, Lisa Yee, Kari Kendra, Sivagurunathan Somasundaram, Robert Z Orlowski, Charles L. Shapiro

Published in: Breast Cancer Research and Treatment | Issue 1/2005

Title: Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel Followed by Epirubicin in Stage II/III Breast Cancer
Authors: Bhuvaneswari Ramaswamy
Steven P Povoski
Chris Rhoades
Joan Allen
Marsha Hauger
Donn Young
William Burak
William Farrar
Lisa Yee
Kari Kendra
Sivagurunathan Somasundaram
Robert Z Orlowski
Charles L. Shapiro
Publication date: 01-09-2005
Publisher: Kluwer Academic Publishers
Published in: Breast Cancer Research and Treatment / Issue 1/2005
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-005-3784-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1/2005

Primary Malignancy after Primary Female Breast Cancer in the South of the Netherlands, 1972–2001

Determination of HER2 Gene Amplification by Fluorescence In situ Hybridization and Concordance with the Clinical Trials Immunohistochemical Assay in Women with Metastatic Breast Cancer Evaluated for Treatment with Trastuzumab

Adjuvant Ovarian Suppression Versus Chemotherapy for Premenopausal, Hormone-responsive Breast Cancer: Quality of Life and Efficacy Tradeoffs

The Pilot Trial on Intraoperative Radiotherapy with Electrons (ELIOT): Update on the Results

Management of Nonpalpable Breast Lesions in a Modern Functional Breast Unit

Systemic Effects of Surgery: Quantitative Analysis of Circulating Basic Fibroblast Growth Factor (bFGF), Vascular Endothelial Growth Factor (VEGF) and Transforming Growth Factor Beta (TGF-β) in Patients with Breast Cancer Who Underwent Limited or Extended Surgery

Keynote webinar | Spotlight on antibody–drug conjugates in cancer